Literature DB >> 11513352

Factor analysis of the Montgomery Asberg Depression Rating Scale in 251 bipolar II and 306 unipolar depressed outpatients.

F Benazzi1.   

Abstract

Symptomatological differences between bipolar II (n = 251) and unipolar (n = 306) depressed outpatients, interviewed with the Structured Clinical Interview for DSM-IV, were studied by Montgomery Asberg Depression Rating Scale factor analysis. Different factors were found in bipolar II [factor 1 (apparent sadness, reported sadness), factor 2 (reduced sleep, reduced appetite), factor 3 (concentration difficulties, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts)], and in unipolar [factor 1 (apparent sadness, reported sadness, inability to feel, suicidal thoughts), factor 2 (concentration difficulties, lassitude, inability to feel, pessimistic thoughts), factor 3 (inner tension, reduced sleep)]. Different factor structure (between bipolar II and unipolar depression) supports previous findings that response to antidepressants and biology may be different in bipolar II and unipolar depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513352     DOI: 10.1016/s0278-5846(01)00190-7

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

1.  Psychotherapy for Bipolar II Disorder: The Role of Interpersonal and Social Rhythm Therapy.

Authors:  Holly A Swartz; Jessica C Levenson; Ellen Frank
Journal:  Prof Psychol Res Pr       Date:  2012-04

2.  [Prospective study using a modified Montgomery-Asberg Depression Scale].

Authors:  H-J Möller; J Schnitker
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

3.  The structure of the Montgomery-Åsberg depression rating scale over the course of treatment for depression.

Authors:  Lena C Quilty; Jennifer J Robinson; Jean-Pierre Rolland; Filip De Fruyt; Frédéric Rouillon; R Michael Bagby
Journal:  Int J Methods Psychiatr Res       Date:  2013-08-19       Impact factor: 4.035

4.  Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?

Authors:  Jihyung Hong; Diego Novick; William Montgomery; Jaume Aguado; Héctor Dueñas; Xiaomei Peng; Josep Maria Haro
Journal:  Clin Pract Epidemiol Ment Health       Date:  2015-03-31

5.  Effects of adjunctive brexpiprazole on calmness and life engagement in major depressive disorder: post hoc analysis of patient-reported outcomes from clinical trial exit interviews.

Authors:  Catherine Weiss; Stine R Meehan; T Michelle Brown; Catherine Gupta; Michael F Mørup; Michael E Thase; Roger S McIntyre; Zahinoor Ismail
Journal:  J Patient Rep Outcomes       Date:  2021-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.